CONMED Corporation Stock

Equities

CNMD

US2074101013

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:02 2024-04-24 pm EDT 5-day change 1st Jan Change
70.01 USD -1.82% Intraday chart for CONMED Corporation -3.78% -36.07%
Sales 2024 * 1.35B Sales 2025 * 1.46B Capitalization 2.16B
Net income 2024 * 108M Net income 2025 * 147M EV / Sales 2024 * 2.23 x
Net Debt 2024 * 841M Net Debt 2025 * 772M EV / Sales 2025 * 2.01 x
P/E ratio 2024 *
19.8 x
P/E ratio 2025 *
15 x
Employees 4,000
Yield 2024 *
1.14%
Yield 2025 *
1.14%
Free-Float 97.76%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.82%
1 week-3.78%
Current month-12.57%
1 month-7.50%
3 months-23.13%
6 months-26.02%
Current year-36.07%
More quotes
1 week
69.78
Extreme 69.78
73.26
1 month
69.78
Extreme 69.78
81.22
Current year
69.78
Extreme 69.78
113.68
1 year
69.78
Extreme 69.78
138.47
3 years
69.78
Extreme 69.78
159.11
5 years
37.66
Extreme 37.66
159.11
10 years
35.51
Extreme 35.51
159.11
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 14-02-28
Director of Finance/CFO 55 18-01-01
Chief Operating Officer 58 14-12-08
Members of the board TitleAgeSince
Director/Board Member 70 15-06-30
Director/Board Member 66 13-07-25
Director/Board Member 62 15-06-30
More insiders
Date Price Change Volume
24-04-24 70.01 -1.82% 1,191,703
24-04-23 71.31 -1.79% 532,872
24-04-22 72.61 -0.04% 341,874
24-04-19 72.64 +2.19% 506,301
24-04-18 71.08 -2.31% 622,688

Delayed Quote Nyse, April 24, 2024 at 04:00 pm EDT

More quotes
CONMED Corporation is a medical technology company, which provides surgical devices and equipment for minimally invasive procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion, and marketing of sports medicine allograft tissue. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
70.01 USD
Average target price
110.5 USD
Spread / Average Target
+57.83%
Consensus